Quantcast

Latest Michael Kauffman Stories

2010-02-01 10:15:00

EMERYVILLE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has appointed Ted W. Love, M.D., Executive Vice President and Head of Research and Development. In addition, Michael Kauffman, M.D., Ph.D., who has served as Interim Chief Medical Officer since November 2009, has been appointed Chief Medical Officer reporting to Dr. Love. In his new role, Dr. Love will report to the Chief Executive Officer and will be responsible for...

2008-07-29 06:00:47

Epix Pharmaceuticals has announced that Michael Kauffman has resigned his position as CEO and director, to pursue other opportunities. Mr Kauffman joined Epix in August 2006 in connection with its acquisition of Predix Pharmaceuticals Holdings, where he had served as CEO since September 2002. Epix also named his replacement with the appointment of Elkan Gamzu, as interim CEO. Mr Gamzu is currently a consultant to the biotechnology and pharmaceutical industries and has held a number of...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related